HOTAIR‐EZH2 inhibitor AC1Q3QWB upregulates CWF19L1 and enhances cell cycle inhibition of CDK4/6 inhibitor palbociclib in glioma

BACKGROUND: Glioblastoma (GBM) is the most common primary tumor in the brain, and the median survival time for GBM patients is only about 14 months; therefore, there is an urgent need for new and more effective strategies. Since cell cycle disorder is a key factor in tumor progression and immortaliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jin, Lv, Shigang, Wu, Miaojing, Wang, Xianggan, Deng, Yan, Li, Yansheng, Li, Kuanxun, Zhao, Hongyu, Zhu, Xingen, Ye, Minhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240863/
https://www.ncbi.nlm.nih.gov/pubmed/32508030
http://dx.doi.org/10.1002/ctm2.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240863/
https://www.ncbi.nlm.nih.gov/pubmed/32508030
http://dx.doi.org/10.1002/ctm2.21

Ejemplares similares